Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
115,694,154
Total 13F shares
82,015,393
Share change
-845,350
Total reported value
$3,300,204,748
Put/Call ratio
66%
Price per share
$40.24
Number of holders
405
Value change
-$139,093,256
Number of buys
207
Number of sells
210

Security key

92686J106

Report period

Q4 2024

Institutions

405

Top holders

10

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
14%
16,619,430
$1,052,176,113 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
8.8%
10,167,614
$643,711,642 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
4.7%
5,380,323
$340,628,249 30 Sep 2024
13F
STATE STREET CORP
13F
Company
4%
4,674,067
$295,915,182 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
1.8%
2,116,438
$133,991,694 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
1.6%
1,874,845
$118,696,515 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.6%
1,863,667
$118,019,817 30 Sep 2024
13F
PERCEPTIVE ADVISORS LLC
13F
Company
1.5%
1,699,987
$107,626,177 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
1.3%
1,472,676
$93,235,117 30 Sep 2024
13F
Pictet Asset Management Holding SA
13F
Company
1.2%
1,361,510
$86,195,973 30 Sep 2024
13F
NORGES BANK
13F
Company
1.1%
1,270,341
$80,425,289 30 Sep 2024
13F
Perpetual Ltd
13F
Company
1.1%
1,269,152
$80,350,012 30 Sep 2024
13F
BRAIDWELL LP
13F
Company
1%
1,156,977
$73,248,214 30 Sep 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.96%
1,115,105
$70,597,297 30 Sep 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.89%
1,033,885
$65,455,259 30 Sep 2024
13F
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
13F
Company
0.87%
1,004,033
$15,859,000 30 Sep 2024
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
0.8%
930,370
$58,901,725 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.76%
876,222
$55,473,615 30 Sep 2024
13F
Hood River Capital Management LLC
13F
Company
0.71%
815,678
$51,640,574 30 Sep 2024
13F
Clearbridge Investments, LLC
13F
Company
0.64%
738,574
$46,759,106 30 Sep 2024
13F
VIKING GLOBAL INVESTORS LP
13F
Company
0.62%
721,926
$45,705,135 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.62%
715,597
$45,304,446 30 Sep 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.58%
674,139
$42,679,741 30 Sep 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.51%
593,528
$37,576,244 30 Sep 2024
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.5%
581,418
$36,809,577 30 Sep 2024
13F
MACQUARIE GROUP LTD
13F
Company
0.49%
568,400
$35,985,000 30 Sep 2024
13F
Artia Global Partners LP
13F
Company
0.46%
532,879
$33,736,569 30 Sep 2024
13F
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.
13F
Company
0.43%
493,950
$31,271,975 30 Sep 2024
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.42%
488,869
$30,950,296 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.42%
481,113
$30,459,265 30 Sep 2024
13F
BAMCO INC /NY/
13F
Company
0.41%
474,644
$30,049,712 30 Sep 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.41%
472,244
$29,897,768 30 Sep 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.4%
463,529
$29,118,891 30 Sep 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.39%
456,460
$28,898,483 30 Sep 2024
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.39%
452,969
$28,677,467 30 Sep 2024
13F
Ensign Peak Advisors, Inc
13F
Company
0.39%
452,011
$28,616,817 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.39%
450,471
$28,519,888 30 Sep 2024
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.38%
441,590
$27,957,062 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.37%
422,833
$26,769,559 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.36%
421,564
$26,689,214 30 Sep 2024
13F
Russell Investments Group, Ltd.
13F
Company
0.35%
406,017
$25,704,934 30 Sep 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.34%
395,891
$25,064,000 30 Sep 2024
13F
EMERALD ADVISERS, LLC
13F
Company
0.29%
339,047
$21,465,066 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.29%
338,807
$21,449,871 30 Sep 2024
13F
UBS Group AG
13F
Company
0.28%
328,959
$20,826,394 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.28%
328,124
$21,590,560 30 Sep 2024
13F
Granahan Investment Management, LLC
13F
Company
0.28%
325,287
$20,593,920 30 Sep 2024
13F
683 Capital Management, LLC
13F
Company
0.28%
320,000
$20,259,200 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.27%
318,000
$20,132,580 30 Sep 2024
13F
Fiera Capital Corp
13F
Company
0.25%
291,318
$18,443,342 30 Sep 2024
13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q4 2024

As of 31 Dec 2024, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 405 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 82,015,393 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, MORGAN STANLEY, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, BRAIDWELL LP, and AMERIPRISE FINANCIAL INC. This page lists 406 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
418
Q4 2024 holders
405
Holder diff
-13
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .